Abstract:The investigation explores 2,3‐dihydroxybenzoyl hydrazine derivative ligands as urease inhibitors, utilizing molecular docking, density functional theory calculations, and molecular dynamics simulations. Key descriptors for inhibitory activity include the HOMO‐LUMO energy gap, dipole moment, and electrostatic potential. Ligand (Z)‐N′‐(3‐aminobenzylidene)‐2,3‐dihydroxybenzohydrazide shows the highest efficacy, suggesting the design of ligands forming additional hydrogen bonds to enhance inhibition. This investigation focuses on a suite of 2,3‐dihydroxybenzoyl hydrazine derivative ligands, examining their viability as urease activity inhibitors and delving into their operative mechanisms. Utilizing molecular docking approaches, the binding patterns and interactive loci of 2,3‐dihydroxybenzoyl hydrazine derivatives with urease were elucidated. The origin of the binding forces between the ligands and urease, along with pertinent descriptors, were scrutinized through an amalgamation of density functional theory calculations and molecular dynamics simulations. The findings indicate that the HOMO‐LUMO energy gap, the dipole moment, and the electrostatic potential serve as robust descriptors of the inhibitory activity exhibited by 2,3‐dihydroxybenzoyl hydrazine derivative ligands against urease. The ligand designated BH‐k emerged as the most efficacious urease inhibitor, with critical hydrogen bonds forming between it and the residues His409, Ala636, and Asp633, in addition to hydrophobic interactions with Arg439. The design of ligands capable of establishing additional hydrogen bonds constitutes an effective strategy to amplify inhibitory efficacy. The results of this research aspire to lay a theoretical foundation for the advancement of novel urease inhibitor designs to counteract health issues emanating from aberrant urease activity.

3-Arylpropionylhydroxamic Acid Derivatives As Helicobacter Pylori Urease Inhibitors: Synthesis, Molecular Docking and Biological Evaluation

Synthesis, Molecular Docking and Kinetic Properties of Β-Hydroxy-β-phenylpropionyl-hydroxamic Acids As Helicobacter Pylori Urease Inhibitors

The Synthesis, Structure and Activity Evaluation of Pyrogallol and Catechol Derivatives As Helicobacter Pylori Urease Inhibitors

Synthesis and Evaluation of N-analogs of 1,2-Diarylethane As Helicobacter Pylori Urease Inhibitors.

The Synthesis and Evaluation of Phenoxyacylhydroxamic Acids As Potential Agents for Helicobacter Pylori Infections

Arylamino Containing Hydroxamic Acids As Potent Urease Inhibitors for the Treatment of Helicobacter Pylori Infection.

Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

Molecular design of hydroxamic acid-based derivatives as urease inhibitors of Helicobacter pylori

Emodin targets the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori : enzymatic inhibition assay with crystal structural and thermodynamic characterization

Synthesis and Biological Evaluation of Triazolones/oxadiazolones As Novel Urease Inhibitors

Synthesis and Biological Evaluation of Dithiobisacetamides as Novel Urease Inhibitors

Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

The synthesis, structure and activity evaluation of secnidazole derivatives as helicobacter pylori urease inhibitors

Pyridylpiperazine-based carbodithioates as urease inhibitors: synthesis and biological evaluation

Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Identification of (N-aryl-N-arylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors and the mechanism exploration

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

Molecular Docking and Molecular Dynamics Simulations of the Urease Inhibitory Activity of 2,3‐Dihydroxybenzohydrazide Derivatives

Synthesis, Evaluation and Mechanism Exploration of 2-(N-(3-nitrophenyl)-n-phenylsulfonyl)aminoacetohydroxamic Acids As Novel Urease Inhibitors.